We are live on
!
Find out more
BC
Bruce & Co Portfolio holdings
AUM
$350M
1-Year Est. Return
33.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.04%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$356M
AUM Growth
-$10.4M
(-2.8%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
68.91%
Holding
37
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caribou Biosciences
CRBU
|
+$449K |
| 2 |
LVTX
LAVA Therapeutics
LVTX
|
+$185K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$871K |
| 2 |
AT&T
T
|
+$170K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.61% |
| 2 | Utilities | 29.35% |
| 3 | Industrials | 13.26% |
| 4 | Communication Services | 5.9% |
| 5 | Financials | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$315B
| $34.7M | 9.72% |
300,372
| – | – |
|
2
U-Haul Holding Co Series N
UHAL.B
$12.2B
| $32.5M | 9.1% |
640,530
| – | – |
|
3
AbbVie
ABBV
$450B
| $25.8M | 7.25% |
191,743
| – | – |
|
4
NextEra Energy
NEE
$185B
| $25.6M | 7.18% |
345,114
| – | – |
|
5
CMS Energy
CMS
$22.8B
| $24.5M | 6.87% |
416,755
| – | – |
|
6
Duke Energy
DUK
$97.5B
| $23.4M | 6.55% |
260,319
| – | – |
|
7
Xcel Energy
XEL
$49.2B
| $23.1M | 6.48% |
371,754
| – | – |
|
8
Pfizer
PFE
$143B
| $19.8M | 5.54% |
538,626
| – | – |
|
9
Allstate
ALL
$64.3B
| $18.2M | 5.1% |
166,844
| – | – |
|
10
Abbott
ABT
$175B
| $18.2M | 5.1% |
166,843
| – | – |
|
|
11
AT&T
T
$152B
| $17.9M | 5.01% |
1,120,254
-10,000
| -0.9% | -$170K |
|
|
12
Apple
AAPL
$4.9T
| $11.4M | 3.2% |
58,801
-5,000
| -8% | -$871K |
|
13
Insteel Industries
IIIN
$602M
| $10.7M | 3% |
343,423
| – | – |
|
14
Avista
AVA
$3.45B
| $8.05M | 2.26% |
205,000
| – | – |
|
15
Bausch Health
BHC
$1.8B
| $7.42M | 2.08% |
925,780
| – | – |
|
|
FOCL
16
EDAP TMS S.A.
FOCL
$204M
| $5.24M | 1.47% |
565,652
| – | – |
|
|
17
U-Haul Holding Co
UHAL
$13.9B
| $4.14M | 1.16% |
74,764
| – | – |
|
|
PRTK
18
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.44M | 0.96% |
1,556,247
| – | – |
|
19
Kodiak Sciences
KOD
$2.67B
| $3.26M | 0.91% |
473,000
| – | – |
|
20
SiriusXM
SIRI
$10.3B
| $2.99M | 0.84% |
65,784
| – | – |
|
21
Newmont
NEM
$95.8B
| $2.8M | 0.79% |
65,600
| – | – |
|
22
Supernus Pharmaceuticals
SUPN
$2.79B
| $2.47M | 0.69% |
82,105
| – | – |
|
|
LVTX
23
DELISTED
LAVA Therapeutics
LVTX
| $1.57M | 0.44% |
771,874
+100,000
| +15% | +$185K |
|
24
Ashland
ASH
$3.14B
| $1.3M | 0.37% |
15,000
| – | – |
|
25
Fate Therapeutics
FATE
$324M
| $956K | 0.27% |
200,000
| – | – |
|
Similar funds
RFS
WMP
PCM
SA
MC
KFG
LAS
GAA
Bruce & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Bruce & Co held 37 positions worth $356M, down 2.8% from $367M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Bruce & Co withdrew a net $15.9M in Q2 2023, reducing 2 holdings. Its largest reduction was Apple, cutting an estimated $871K.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 36% a quarter earlier, followed by Utilities and Industrials.
Against the trend, Bruce & Co added an estimated $449K to Caribou Biosciences.
- Bruce & Co added most to Caribou Biosciences in Q2 2023, an estimated $449K increase.
- Bruce & Co's biggest Q2 2023 reduction was Apple, cutting an estimated $871K.
- Bruce & Co's ten largest holdings make up 69% of its $356M portfolio in Q2 2023.
- Bruce & Co opened 0 new positions and closed 0 in Q2 2023.
- Bruce & Co's portfolio value fell 2.8% quarter-over-quarter to $356M.
Based on Bruce & Co's 13F filing for Q2 2023, filed 8 Aug 2023.